Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Preiss

Showing results (31-40 of 160) with videos related to

Pageof 16
Sort By:
Nature Reviews. Nephrology|July 4, 2017
Cardiovascular disease: PCSK9 inhibition: a new player in cholesterol-lowering therapies?David Preiss, Colin Baigent
Clinical Endocrinology|December 11, 2008
Lipids, lipid modifying agents and cardiovascular risk: a review of the evidenceDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|January 27, 2019
Research digest: vitamin D supplementationDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|November 13, 2017
Research digest: hypoglycaemia and glucose variabilityNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|May 25, 2016
Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failureNaveed Sattar, David Preiss
Current Opinion in Lipidology|November 16, 2013
Choice of medical therapy to lower triglycerides in those at risk of pancreatitisDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|July 29, 2018
Research digest: heart failure in diabetes comes into focusNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|August 3, 2016
Research digest: NAFLD in the spotlightDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|April 3, 2017
Tightening our understanding of intensive glycaemic controlWilliam G Herrington, David Preiss
BMJ (Clinical Research Ed.)|July 28, 2011
Intensive glucose lowering treatment in type 2 diabetesDavid Preiss, Kausik K Ray
Pageof 16

Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
Nature Reviews. Nephrology|July 4, 2017
Cardiovascular disease: PCSK9 inhibition: a new player in cholesterol-lowering therapies?David Preiss, Colin Baigent
Clinical Endocrinology|December 11, 2008
Lipids, lipid modifying agents and cardiovascular risk: a review of the evidenceDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|January 27, 2019
Research digest: vitamin D supplementationDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|November 13, 2017
Research digest: hypoglycaemia and glucose variabilityNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|May 25, 2016
Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failureNaveed Sattar, David Preiss
Current Opinion in Lipidology|November 16, 2013
Choice of medical therapy to lower triglycerides in those at risk of pancreatitisDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|July 29, 2018
Research digest: heart failure in diabetes comes into focusNaveed Sattar, David Preiss
The Lancet. Diabetes & Endocrinology|August 3, 2016
Research digest: NAFLD in the spotlightDavid Preiss, Naveed Sattar
The Lancet. Diabetes & Endocrinology|April 3, 2017
Tightening our understanding of intensive glycaemic controlWilliam G Herrington, David Preiss
BMJ (Clinical Research Ed.)|July 28, 2011
Intensive glucose lowering treatment in type 2 diabetesDavid Preiss, Kausik K Ray
Pageof 16